Table 3.
Adjust variables | Crude analysis | Adjusted analysis |
Total (n = 351) | ||
Age starting thiopurine older than 40 vs 40 or younger | OR (95%CI) | |
Female | 3.6 (1.9-7.1) | 4.0 (1.9-8.3) |
Male | 1.2 (0.6-2.6) | 1.3 (0.6-3.0) |
Predictors of thiopurine-related adverse events as determined by multivariate analysis. A significant age-by-gender interaction was observed in both crude and adjusted analyses, P-value = 0.03 and 0.04 respectively.